|
|
Lupin Limited is a leading Indian pharmaceutical group. Its products are used to treat tuberculosis, diabetes, asthma, cardiovascular diseases, infections, etc. The group's activity is organized around 2 areas:
- design and production of generic and brand-name formulations;
- production of active pharmaceutical ingredients.
At the end of March 2020, the group had 15 production sites India (12), the United States, Mexico and Brazil.
Net sales break down geographically as follows: India (37.3%), the United States (37.2%), Japan (0.7%) and other (24.8%).
|
|
|
| 2020 | 2021 | Delta | | Pharmaceutical Goods | 149 892.00 | 97.5% | 149 139.00 | 98.4% | -0.5% |
| Export Benefits and Other Incentives | 2 086.20 | 1.4% | 1 173.50 | 0.8% | -43.75% |
| Business Compensation and Settlement | 77.60 | 0.1% | 827.20 | 0.5% | +965.98% |
| Insurance Claims | 42.30 | - | 206.60 | 0.1% | +388.42% |
| Research Services | 1 536.20 | 1% | 130.90 | 0.1% | -91.48% |
| Miscellaneous | 84.00 | 0.1% | 127.40 | 0.1% | +51.67% |
| Service Charges | 29.50 | - | 25.00 | - | -15.25% |
| INR in Million |
|
|
|
| 2020 | 2021 | Delta | | India | 58 647.50 | 38.1% | 59 316.90 | 39.1% | +1.14% |
| United States | 56 431.50 | 36.7% | 54 023.10 | 35.6% | -4.27% |
| Others | 37 578.50 | 24.4% | 36 015.00 | 23.8% | -4.16% |
| Japan | 1 090.10 | 0.7% | 2 274.60 | 1.5% | +108.66% |
| INR in Million |
|
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
| Stock A |
1 |
454,552,687 |
240,878,287 |
53.0% |
0 |
0.0% |
53.0% |
|
|
|
| Name | Equities | % | | Lupin Investments Pvt Ltd. | 205,770,835 |
45.3% | | Life Insurance Corporation of India (Investment Portfolio) | 38,123,322 |
8.39% | | ICICI Prudential Asset Management Co. Ltd. | 23,069,847 |
5.08% | | HDFC Asset Management Co. Ltd. (Invt Mgmt) | 19,818,333 |
4.36% | | The Vanguard Group, Inc. | 7,462,515 |
1.64% | | SBI Funds Management Pvt Ltd. | 6,794,269 |
1.49% | | Norges Bank Investment Management | 6,039,098 |
1.33% | | BlackRock Fund Advisors | 5,364,740 |
1.18% | | Franklin Templeton Asset Management (India) Pvt. Ltd. | 4,924,266 |
1.08% | | Nippon Life India Asset Management Ltd. (Invt Mgmt) | 4,815,896 |
1.06% |
|
|
|
|
| - Bloomberg Code : |
LUPIN:IN |
| - Reuters Code : |
LUPIN.BO |
| - Datastream Code : |
|
|
| Company contact information |
|
Lupin Limited B/4 Laxmi Towers, Bandra Kurla Complex IN-400 051 Mumbai, Maharashtra Phone : +91 22 6640 2222 Fax : +91 22 6640 2130 web site : http://www.lupinworld.com |
|
|
Sector Other Pharmaceuticals
Connections : Lupin Limited |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
